智通财经APP获悉，艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。
消息面上，高盛发布的最新研报显示，该行认为中国诊断行业，包括独立临床实验室(ICL)和体外诊断(IVD)公司，在2025年第三季度开始显现复苏迹象。在ICL板块，金域医学和迪安诊断均报告运营现金流改善，同时营收环比增长，利润率也扩大，尽管两家公司均未达到营收目标。该行认为这些趋势表明，行业整合已经开始。
中信建投也在研报中指出，ICL板块25第三季度收入降幅有所缩窄，利润端仍受减值影响。该行指出，ICL行业增速存在不确定性，但是成本和质量控制较好的企业有望实现份额提升。据悉，从上半年业绩来看，艾迪康的毛利达到了4.5亿，净利润4300万，是三家头部ICL企业里面净利润最好的，迪安诊断期内扭亏为盈，实现了1027万的净利润；金域仍处于亏损状态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.